S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q3 2024

RTW Investments

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$6.91B
Total portfolio value
Positions
68
Reported securities
Top Holding
MDGL
6.1% $423.1M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$423.1M6.12%$212.22$528.10+148.8%
6.1%
AXSMAXSOME THERAPEUTICS INC$376.5M5.45%$89.87$244.31+171.8%
5.5%
RNAMAVIDITY BIOSCIENCES INC$373.5M5.40%β€”β€”
5.4%
ARGXARGENX SE$354.8M5.13%$542.08$939.68+73.3%
5.1%
NTRANATERA INC$329.2M4.76%$126.95$279.32+120.0%
4.8%
RCKTROCKET PHARMACEUTICALS INC$326.7M4.73%$18.47$3.84-79.2%
4.7%
PTCTPTC THERAPEUTICS INC$274.3M3.97%$37.10$83.31+124.6%
4.0%
DYNDYNE THERAPEUTICS INC$244.9M3.54%$35.92$23.07-35.8%
3.5%
PTGXPROTAGONIST THERAPEUTICS INC$244.2M3.53%$45.00$131.62+192.5%
3.5%
BRKRBRUKER CORP$240.4M3.48%$68.50$61.64-10.0%
3.5%
INSMINSMED INC$238.9M3.46%$73.00$111.60+52.9%
3.5%
ACADACADIA PHARMACEUTICALS INC$210.8M3.05%$15.38$25.97+68.9%
3.0%
MRUSMERUS N V$208.3M3.01%β€”β€”
3.0%
GERNGERON CORP$200.3M2.90%$4.54$1.36-70.0%
2.9%
MASIMASIMO CORP$195.0M2.82%$133.33β€”
2.8%
ALKSALKERMES PLC$186.3M2.69%$27.99$54.58+95.0%
2.7%
AKROAKERO THERAPEUTICS INC$169.8M2.46%β€”β€”
2.5%
APGEAPOGEE THERAPEUTICS INC$159.3M2.31%$58.74$132.91+126.3%
2.3%
PENPENUMBRA INC$154.6M2.24%$194.31$318.57+64.0%
2.2%
IMCRIMMUNOCORE HLDGS PLC$151.6M2.19%$31.13$32.50+4.4%
2.2%
CYTKCYTOKINETICS INC$143.7M2.08%$52.80$86.49+63.8%
2.1%
SYKSTRYKER CORPORATION$143.4M2.07%$355.21$326.54-8.1%
2.1%
RDNTRADNET INC$125.5M1.82%$69.39$68.75-0.9%
1.8%
ESTAESTABLISHMENT LABS HLDGS INC$114.5M1.66%$43.27$89.25+106.3%
1.7%
IMTXIMMATICS N.V$114.1M1.65%$11.41$9.95-12.8%
1.6%
TARSTARSUS PHARMACEUTICALS INC$112.2M1.62%$32.89$65.44+99.0%
1.6%
RAREULTRAGENYX PHARMACEUTICAL IN$109.3M1.58%$55.55$33.47-39.8%
1.6%
SYRESPYRE THERAPEUTICS INC$95.8M1.39%$29.41$86.63+194.6%
1.4%
CRGXCARGO THERAPEUTICS INC$75.6M1.09%β€”β€”
1.1%
ARVNARVINAS INC$68.5M0.99%$24.63$8.39-65.9%
1.0%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (8)

TickerIssuerNotionalSince Filing
GERNGERON CORP$200.3M-70.0%
SYKSTRYKER CORPORATION$143.4M-8.1%
ORKAORUKA THERAPEUTICS INC$45.4M
BIOABIOAGE LABS INC$16.4M
XNCRXENCOR INC$11.6M
WVEWAVE LIFE SCIENCES LTD$7.4M
IDYAIDEAYA BIOSCIENCES INC$6.3M
ARTVARTIVA BIOTHERAPEUTICS INC$2.3M

Exited Positions (8)

TickerIssuerNotional
ISRGINTUITIVE SURGICAL INC$90.1M
VCELVERICEL CORP$36.8M
FULCFULCRUM THERAPEUTICS INC$36.2M
KYTXKYVERNA THERAPEUTICS INC$13.9M
VRDNVIRIDIAN THERAPEUTICS INC$7.9M
ABIOARCA BIOPHARMA INC$5.4M
CUTRQCUTERA INC$2.0M
SGMTSAGIMET BIOSCIENCES INC$1.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CGEMCULLINAN THERAPEUTICS INC$10.2M+62.1%
OBIOORCHESTRA BIOMED HLDGS INC$-3.6M+46.0%
EPIXESSA PHARMA INC$7.7M+41.9%
STOKSTOKE THERAPEUTICS INC$0.1M+10.1%
AKROAKERO THERAPEUTICS INC$42.4M+9.0%
PENPENUMBRA INC$21.1M+7.2%+64.0%
DYNDYNE THERAPEUTICS INC$19.5M+6.8%-35.8%
URGNUROGEN PHARMA LTD$-11.6M+6.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
RAREULTRAGENYX PHARMACEUTICAL IN$-24.7M-39.6%-39.8%
TSHATAYSHA GENE THERAPIES INC$-12.1M-20.5%
SABSSAB BIOTHERAPEUTICS INC$-0.7M-17.2%
INSMINSMED INC$-5.0M-10.1%+52.9%
AXSMAXSOME THERAPEUTICS INC$3.5M-9.6%+171.8%
RNAMAVIDITY BIOSCIENCES INC$13.8M-7.7%
ARVNARVINAS INC$-10.5M-6.3%-65.9%
ALKSALKERMES PLC$16.2M-5.7%+95.0%
← Back to Hedge Funds